Histologically 0 14 0 14 O
confirmed 15 24 15 24 O
, 24 25 24 25 O
stage 26 31 26 31 B-cancer
IV 32 34 32 34 I-cancer
or 35 37 35 37 I-cancer
recurrent 38 47 38 47 I-cancer
non 48 51 48 51 I-cancer
- 51 52 51 52 I-cancer
small 52 57 52 57 I-cancer
cell 58 62 58 62 I-cancer
lung 63 67 63 67 I-cancer
cancer 68 74 68 74 I-cancer
with 75 79 75 79 O
no 80 82 80 82 O
prior 83 88 83 88 B-treatment
systemic 89 97 89 97 I-treatment
anticancer 98 108 98 108 I-treatment
therapy 109 116 109 116 I-treatment
given 117 122 117 122 O
as 123 125 123 125 O
primary 126 133 126 133 B-treatment
therapy 134 141 134 141 I-treatment
for 142 145 142 145 O
advanced 146 154 146 154 O
or 155 157 155 157 O
metastatic 158 168 158 168 B-cancer
disease 169 176 169 176 I-cancer

Participants 0 12 177 189 O
with 13 17 190 194 O
active 18 24 195 201 O
, 24 25 201 202 O
known 26 31 203 208 O
or 32 34 209 211 O
suspected 35 44 212 221 O
autoimmune 45 55 222 232 B-chronic_disease
disease 56 63 233 240 I-chronic_disease

Patients 0 8 241 249 O
with 9 13 250 254 O
untreated 14 23 255 264 O
central 24 31 265 272 B-cancer
nervous 32 39 273 280 I-cancer
system 40 46 281 287 I-cancer
metastases 47 57 288 298 I-cancer

